Related references
Note: Only part of the references are listed.Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II)
Silvio Danese et al.
GUT (2019)
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
Kenneth F. Baker et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases
C. Gregoire et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Alicaforsen for the treatment of inflammatory bowel disease
Vipul Jairath et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases
Clara Abraham et al.
GASTROENTEROLOGY (2017)
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study
Bruce E. Sands et al.
GASTROENTEROLOGY (2017)
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panes et al.
GUT (2017)
Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?
Massimo C. Fantini et al.
INFLAMMATORY BOWEL DISEASES (2017)
The Ileitis of Ulcerative Colitis. Why Is It Not Crohn's Disease? Reply
Matthew J. Hamilton et al.
INFLAMMATORY BOWEL DISEASES (2017)
Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis
Neeraj Narula et al.
INFLAMMATORY BOWEL DISEASES (2017)
Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease
Ying Nie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Novel therapeutic targets for inflammatory bowel disease
Marjorie Argollo et al.
JOURNAL OF AUTOIMMUNITY (2017)
Gammadelta T Cells in Crohn's Disease: A New Player in the Disease Pathogenesis?
Ignacio Catalan-Serra et al.
JOURNAL OF CROHNS & COLITIS (2017)
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
The IBD interactome: an integrated view of aetiology, pathogenesis and therapy
Heitor S. P. de Souza et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease
Ole Haagen Nielsen et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Novel Targeted Therapies for Inflammatory Bowel Disease
Mehmet Coskun et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease
Fei Mao et al.
ONCOTARGET (2017)
Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
Benjamin L. Cohen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
Benjamin L. Cohen et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Mesenchymal stem/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission
Maneesh Dave et al.
CURRENT OPINION IN GASTROENTEROLOGY (2017)
Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
N. S. Ding et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
James B. Canavan et al.
GUT (2016)
Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity
Antonella D'Ambrosio et al.
JOURNAL OF CROHNS & COLITIS (2016)
The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses
T. Dhere et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
A. Stallmach et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease
Stephan R. Targan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Innate lymphoid cells in inflammatory bowel diseases
C. P. Peters et al.
IMMUNOLOGY LETTERS (2016)
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
Jeffrey A. Cohen et al.
LANCET NEUROLOGY (2016)
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets
Vipul Yadav et al.
TRANSLATIONAL RESEARCH (2016)
Modulation of microbiota as treatment for intestinal inflammatory disorders: an uptodate
Antonella Gallo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Laquinimod in the treatment of multiple sclerosis: a review of the data so far
Jan Thoene et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation
Konrad Aden et al.
CELL REPORTS (2016)
Safety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis
Naoki Yoshimura et al.
GASTROENTEROLOGY (2015)
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Jacob S. Lee et al.
IMMUNITY (2015)
The TGF-β/Smad System in IBD Pathogenesis
Silvia Sedda et al.
INFLAMMATORY BOWEL DISEASES (2015)
Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Maneesh Dave et al.
INFLAMMATORY BOWEL DISEASES (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease
Giovanni Monteleone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A phase II study of laquinimod in Crohn's disease
Geert D'Haens et al.
GUT (2015)
Systematic Review of Complementary and Alternative Medicine Treatments in Inflammatory Bowel Diseases
J. Langhorst et al.
JOURNAL OF CROHNS & COLITIS (2015)
Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells
E. Macho-Fernandez et al.
MUCOSAL IMMUNOLOGY (2015)
Review article: anti-adhesion therapies for inflammatory bowel disease
T. Lobaton et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
First Multicenter Study of Modified Release Phosphatidylcholine LT-02 in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses
Max Karner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy
Geoffrey M. Forbes et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn's Disease
William J. Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Risks of Serious Infection or Lymphoma With Anti-Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review
Parambir S. Dulai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Interleukin-6 and its receptors: A highly regulated and dynamic system
Janina Wolf et al.
CYTOKINE (2014)
Development of Drugs to Target Interactions Between Leukocytes and Endothelial Cells and Treatment Algorithms for Inflammatory Bowel Diseases
Silvio Danese et al.
GASTROENTEROLOGY (2014)
The Risk of Malignancy Associated with the Use of Biological Agents in Patients with Inflammatory Bowel Disease
Parambir S. Dulai et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2014)
Mechanisms That Mediate the Development of Fibrosis in Patients With Crohn's Disease
Chao Li et al.
INFLAMMATORY BOWEL DISEASES (2014)
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
T. L. Vollmer et al.
JOURNAL OF NEUROLOGY (2014)
IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism
A. Eken et al.
MUCOSAL IMMUNOLOGY (2014)
IL-6 biology: implications for clinical targeting in rheumatic disease
Leonard H. Calabrese et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
IL-6 Stimulates Intestinal Epithelial Proliferation and Repair after Injury
Kristine A. Kuhn et al.
PLOS ONE (2014)
A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
Toshio Tanaka et al.
SEMINARS IN IMMUNOLOGY (2014)
gamma delta T cells for cancer immunotherapy A systematic review of clinical trials
Jonathan P. H. Fisher et al.
ONCOIMMUNOLOGY (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies
Alexandra D. Frolkis et al.
GASTROENTEROLOGY (2013)
Induced and Natural Regulatory T Cells in the Development of Inflammatory Bowel Disease
Christopher G. Mayne et al.
INFLAMMATORY BOWEL DISEASES (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease
Mehmet Coskun et al.
PHARMACOLOGICAL RESEARCH (2013)
Human Umbilical Cord-Derived Mesenchymal Stem Cells Downregulate Inflammatory Responses by Shifting the Treg/Th17 Profile in Experimental Colitis
Liren Li et al.
PHARMACOLOGY (2013)
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease
F. Zorzi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Inflammatory bowel disease: A Canadian burden of illness review
Angela Rocchi et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
Kentaro Akiyama et al.
CELL STEM CELL (2012)
Administration of CD4+CD25highCD127- Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children
Natalia Marek-Trzonkowska et al.
DIABETES CARE (2012)
Systemic Infusion of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Experimental Colitis in Mice
Xiao-Wen He et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease
Cosimo Prantera et al.
GASTROENTEROLOGY (2012)
Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
Pierre Desreumaux et al.
GASTROENTEROLOGY (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease
Jun Liang et al.
GUT (2012)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
John J. O'Shea et al.
IMMUNITY (2012)
Mesenchymal Stem Cell-Mediated Immature Dendritic Cells Induce Regulatory T Cell-Based Immunosuppressive Effect
Yong-Soo Choi et al.
IMMUNOLOGICAL INVESTIGATIONS (2012)
Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease
Giovanni Monteleone et al.
MOLECULAR THERAPY (2012)
Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice
J. H. Cox et al.
MUCOSAL IMMUNOLOGY (2012)
IL-12 family cytokines: immunological playmakers
Dario A. A. Vignali et al.
NATURE IMMUNOLOGY (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu et al.
PLOS ONE (2012)
Association of ustekinumab and briakinumab with major adverse cardiovascular events An appraisal of meta-analyses and industry sponsored pooled analyses to date
Thrasivoulos Tzellos et al.
DERMATO-ENDOCRINOLOGY (2012)
Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms
Suraj Kachgal et al.
ANGIOGENESIS (2011)
Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Mice Trinitrobenzene Sulfonic Acid (TNBS)-Induced Colitis
Lu Liang et al.
CELL TRANSPLANTATION (2011)
Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events A Meta-analysis of Randomized Controlled Trials
Caitriona Ryan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Insight into the mechanism of laquinimod action
W. Brueck et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q
Svetlana Pidasheva et al.
PLOS ONE (2011)
The outs and the ins of sphingosine-1-phosphate in immunity
Sarah Spiegel et al.
NATURE REVIEWS IMMUNOLOGY (2011)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study
Marjolijn Duijvestein et al.
GUT (2010)
Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics
Shobha Thangada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
An update on sphingosine-1-phosphate and other sphingolipid mediators
Henrik Fyrst et al.
NATURE CHEMICAL BIOLOGY (2010)
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Review: Anti-adhesion molecule therapy for inflammatory bowel disease
Subrata Ghosh et al.
Therapeutic Advances in Gastroenterology (2010)
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127-T regulatory cells
Piotr Trzonkowski et al.
CLINICAL IMMUNOLOGY (2009)
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression
Massimo C. Fantini et al.
GASTROENTEROLOGY (2009)
Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses
Manuel A. Gonzalez et al.
GASTROENTEROLOGY (2009)
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
E. Gonzalez-Rey et al.
GUT (2009)
Janus kinases in immune cell signaling
Kamran Ghoreschi et al.
IMMUNOLOGICAL REVIEWS (2009)
Alterations of Phospholipid Concentration and Species Composition of the Intestinal Mucus Barrier in Ulcerative Colitis: A Clue to Pathogenesis
Annika Braun et al.
INFLAMMATORY BOWEL DISEASES (2009)
Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity
Takashi Yabana et al.
JOURNAL OF PATHOLOGY (2009)
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study
Mark S. Silverberg et al.
NATURE GENETICS (2009)
Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region
Jeffrey C. Barrett et al.
NATURE GENETICS (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease
Arthur Kaser et al.
CELL (2008)
Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice
Eran Elinav et al.
GASTROENTEROLOGY (2008)
γδ T lymphocytes:: a new type of regulatory T cells suppressing murine 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis
Jorg C. Hoeffmann et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats
Yujiro Hayashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
IL-23 and Th17 cytokines in intestinal homeostasis
K. J. Maloy et al.
MUCOSAL IMMUNOLOGY (2008)
Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease
Masayuki Saruta et al.
CLINICAL IMMUNOLOGY (2007)
The IL23 axis plays a key role in the pathogenesis of IBD
Dermot McGovern et al.
GUT (2007)
Natalizumab for the treatment of active Crohn's disease: Results of the ENCORE trial
Stephan R. Targan et al.
GASTROENTEROLOGY (2007)
Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate
Rajita Pappu et al.
SCIENCE (2007)
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1
Jochen Hampe et al.
NATURE GENETICS (2007)
Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease
S. Zeissig et al.
GUT (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis
M Takahashi et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Reduced Paneth cell α-defensins in ileal Crohn's disease
J Wehkamp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Natalizumab induction and maintenance therapy for Crohn's disease
WJ Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease
G Monteleone et al.
GASTROENTEROLOGY (2005)
Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease
J Maul et al.
GASTROENTEROLOGY (2005)
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease
H Ito et al.
GASTROENTEROLOGY (2004)
Mucosal T cells bearing TCRγδ play a protective role in intestinal inflammation
K Inagaki-Ohara et al.
JOURNAL OF IMMUNOLOGY (2004)
Cutting edge:: TGF-β signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+ CD25+ T cells
S Huber et al.
JOURNAL OF IMMUNOLOGY (2004)
Anti-interleukin-12 antibody for active Crohn's disease
PJ Mannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells
JR Mora et al.
NATURE (2003)
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates
SM Devine et al.
BLOOD (2003)
A controlled trial of natalizumab for relapsing multiple sclerosis.
DH Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses
G Trinchieri et al.
IMMUNITY (2003)
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
BR Yacyshyn et al.
GUT (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Transforming growth factor-beta in T-cell biology
L Gorelik et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Preliminary study of ciprofloxacin in active Crohn's disease
GL Arnold et al.
INFLAMMATORY BOWEL DISEASES (2002)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
IL-6 is required for the development of Th1 cell-mediated murine colitis
M Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
